Effectiveness of NeuroMuscular Taping in a Population of Post Stroke Hemiplegic Patients Suffering From Painful Shoulder Syndrome - Randomized Controlled Trial (RCT)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 40
- Locations
- 2
- Primary Endpoint
- Pain
Study Overview
Brief Summary
Painful Shoulder Syndrome is a frequent complication after stroke occurring in between 5% and 84% of patients, often having a strong impact on their well-being and resulting in delays achieving rehabilitative objectives.
The aim of the study is to demonstrate the effectiveness of Neuromuscular Taping in a population of post-stroke hemiplegic patients suffering from painful shoulder syndrome with respect to pain, spasticity and range of motion.
Detailed Description
The study will use two groups according to the methodology of Randomized Controlled Trials. Both components of the two groups were treated by four rehabilitation sessions defined as "standard". This involves joint health and passive mobility for the glenohumeral and scapulothoracic joints for a period of about 45 minutes each.
The patients of the sample group underwent the application of the NeuroMuscular Taping (NMT) before each rehabilitative session. The control group was addressed exclusively to the "standard" treatment. The sessions were spaced apart about five days to ensure the optimum adhesion of NMT.
The results were evaluated by administering rating scales for pain (VAS) and spasticity (Modified Ashworth Scale). The ROM was evaluated using the manual goniometer. The outcomes (Pain, Spasticity, ROM) were assessed at base line, before and after each treatment session and at 1 month follow up.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Investigator)
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Right or left hemiplegia resulting from an ischemic or hemorrhagic stroke
- •Painful Shoulder Syndrome, with pain at rest and during functional movement of the shoulder girdle
- •Spasticity with an Ashworth score greater than or equal to 1.
Exclusion Criteria
- •Flaccidity
- •Thermoalgesic sensitivity deficits
- •Previous surgery to the shoulder
- •Cognitive impairment
- •Taking anti-inflammatory drugs and/or muscle relaxants during the course of the trial
Outcomes
Primary Outcomes
Pain
Time Frame: Before and after each treatment session and at 1 month follow up
The investigators assessed this outcome with a Visual Analogue Scale (VAS).
Secondary Outcomes
- Spasticity(Before and after each treatment session and at 1 month follow up)
- ROM(Before and after each treatment session and at one month follow up.)
Investigators
paolo pillastrini
Associate Professor and President of Baccaluareate Course in Physiotherapy
University of Bologna